• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高全身性炎症反应指数水平与下肢深静脉血栓形成风险增加相关:一项大型回顾性研究。

High systemic inflammation response index level is associated with an increased risk of lower extremity deep venous thrombosis: a large retrospective study.

机构信息

Department of Orthopedics, People's Hospital of Deyang City, Deyang, China.

Department of Orthopedics, The First Affiliated Hospital of Dalian Medical University, Dalian, China.

出版信息

Ann Med. 2023;55(2):2249018. doi: 10.1080/07853890.2023.2249018.

DOI:10.1080/07853890.2023.2249018
PMID:37604134
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10443988/
Abstract

BACKGROUND

The association between inflammation and venous thromboembolism (VTE) has attracted increasing research interest. Recently, the systemic inflammation response index (SIRI) has been proposed as a novel inflammatory biomarker, but its potential association with lower extremity deep venous thrombosis (LEDVT) has not been investigated. Thus, this study aimed to explore the association between SIRI and LEDVT risk in a large sample over a 10-year period (2012-2022).

METHODS

All hospitalized patients who underwent lower extremity compression ultrasonography (CUS) examinations were consecutively identified from our hospital information system database. Multivariate logistic regression analysis was used to investigate the association between SIRI and LEDVT risk. Sensitivity, restricted cubic spline and subgroup analyses were also performed.

RESULTS

In total, 12643 patients were included, and 1346 (10.6%) LEDVT events occurred. After full adjustment, a higher SIRI level was significantly associated with an increased risk of LEDVT (odds ratio [OR] = 1.098, 95% confidence interval []: 1.068-1.128,  < 0.001), and patients in quartile 4 had a 2.563-fold higher risk of LEDVT than those in quartile 1 (95% : 2.064-3.182,  < 0.001). A nonlinear relationship was observed ( for nonlinearity < 0.001), with an inflection point of 4.17. Below this point, each unit increase in SIRI corresponded to a 35.3% increase in LEDVT risk (95% : 1.255-1.458,  < 0.001). No significant difference was found above the inflection point (OR = 1.015, 95% : 0.963-1.069,  = 0.582). Sensitivity and subgroup analyses confirmed the robustness of the association. This association also existed in both distal and proximal LEDVT.

CONCLUSION

A High SIRI is significantly associated with an increased risk of LEDVT in hospitalized patients. Given that the SIRI is a readily available biomarker in clinical settings, its potential clinical use deserves further exploration.

摘要

背景

炎症与静脉血栓栓塞症(VTE)之间的关联引起了越来越多的研究兴趣。最近,全身性炎症反应指数(SIRI)被提出作为一种新的炎症生物标志物,但它与下肢深静脉血栓形成(LEDVT)的潜在关联尚未得到研究。因此,本研究旨在探讨 SIRI 与 10 年间(2012-2022 年)住院患者 LEDVT 风险之间的关系。

方法

从我院的信息系统数据库中连续确定所有接受下肢压迫超声检查的住院患者。采用多变量逻辑回归分析来探讨 SIRI 与 LEDVT 风险之间的关系。还进行了敏感性、限制性立方样条和亚组分析。

结果

共纳入 12643 例患者,发生 1346 例(10.6%)LEDVT 事件。经完全调整后,较高的 SIRI 水平与 LEDVT 风险增加显著相关(比值比 [OR] = 1.098,95%置信区间 [CI]:1.068-1.128, < 0.001),且 SIRI 四分位 4 组患者的 LEDVT 风险是四分位 1 组的 2.563 倍(95% CI:2.064-3.182, < 0.001)。观察到非线性关系( for nonlinearity < 0.001),拐点为 4.17。在此点以下,SIRI 每增加一个单位,LEDVT 风险增加 35.3%(95% CI:1.255-1.458, < 0.001)。在此点以上,无显著差异(OR = 1.015,95% CI:0.963-1.069, = 0.582)。敏感性和亚组分析证实了该关联的稳健性。该关联在远端和近端 LEDVT 中均存在。

结论

高 SIRI 与住院患者 LEDVT 风险增加显著相关。鉴于 SIRI 是临床中易于获得的生物标志物,其潜在的临床应用值得进一步探索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0e/10443988/633963e615c0/IANN_A_2249018_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0e/10443988/6b3791c0c725/IANN_A_2249018_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0e/10443988/4c1bb2eabbb2/IANN_A_2249018_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0e/10443988/8d065d8acfab/IANN_A_2249018_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0e/10443988/633963e615c0/IANN_A_2249018_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0e/10443988/6b3791c0c725/IANN_A_2249018_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0e/10443988/4c1bb2eabbb2/IANN_A_2249018_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0e/10443988/8d065d8acfab/IANN_A_2249018_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b0e/10443988/633963e615c0/IANN_A_2249018_F0004_C.jpg

相似文献

1
High systemic inflammation response index level is associated with an increased risk of lower extremity deep venous thrombosis: a large retrospective study.高全身性炎症反应指数水平与下肢深静脉血栓形成风险增加相关:一项大型回顾性研究。
Ann Med. 2023;55(2):2249018. doi: 10.1080/07853890.2023.2249018.
2
Association between systemic immune-inflammation index and risk of lower extremity deep venous thrombosis in hospitalized patients: a 10-year retrospective analysis.住院患者全身免疫炎症指数与下肢深静脉血栓形成风险的相关性:一项10年回顾性分析
Front Cardiovasc Med. 2023 Jun 16;10:1211294. doi: 10.3389/fcvm.2023.1211294. eCollection 2023.
3
High Prevalence and Mortality Associated with Upper Extremity Deep Venous Thrombosis in Hospitalized Patients at a Tertiary Care Center.在一家三级医疗中心,住院患者上肢深静脉血栓形成的高患病率及死亡率
Ann Vasc Surg. 2020 May;65:55-65. doi: 10.1016/j.avsg.2019.10.055. Epub 2019 Oct 24.
4
C-reactive protein is a predictor for lower-extremity deep venous thrombosis in patients with primary intracerebral hemorrhage.C 反应蛋白是预测原发性脑出血患者下肢深静脉血栓形成的指标。
Eur J Med Res. 2024 Jun 6;29(1):311. doi: 10.1186/s40001-024-01842-3.
5
Relationship between the site of thrombosis and the prevalence of pulmonary embolism in acute lower extremity deep venous thrombosis.下肢深静脉血栓形成急性期血栓部位与肺栓塞患病率的关系。
J Vasc Surg Venous Lymphat Disord. 2020 Sep;8(5):725-733. doi: 10.1016/j.jvsv.2019.11.010. Epub 2020 Feb 14.
6
Anatomic distribution of lower extremity deep venous thrombosis is associated with an increased risk of pulmonary embolism: A 10-year retrospective analysis.下肢深静脉血栓形成的解剖分布与肺栓塞风险增加相关:一项10年回顾性分析。
Front Cardiovasc Med. 2023 Mar 22;10:1154875. doi: 10.3389/fcvm.2023.1154875. eCollection 2023.
7
[Construction and validation of a predictive model for early occurrence of lower extremity deep venous thrombosis in ICU patients with sepsis].[脓毒症重症监护病房患者下肢深静脉血栓形成早期发生预测模型的构建与验证]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 May;36(5):471-477. doi: 10.3760/cma.j.cn121430-20231117-00985.
8
The impact of pelvic and lower extremity fractures on the incidence of lower extremity deep vein thrombosis in high-risk trauma patients. Winner of the Best Paper Award from the Gold Medal Forum.骨盆及下肢骨折对高危创伤患者下肢深静脉血栓形成发生率的影响。金牌论坛最佳论文奖得主。
Am Surg. 2003 Jun;69(6):459-63; discussion 464.
9
[Analysis of the Incidence of Lower Extremity Venous Thrombosis and Its Related Risk Factors in Admitted Patients with Lung Cancer].[肺癌住院患者下肢静脉血栓形成的发病率及其相关危险因素分析]
Zhongguo Fei Ai Za Zhi. 2018 Oct 20;21(10):761-766. doi: 10.3779/j.issn.1009-3419.2018.10.05.
10
Preoperative Systemic Immune-Inflammatory Index as a Predictive Biomarker for Lower Extremity Deep Vein Thrombosis after Breast Cancer Surgery: Stratified Nursing Intervention to Reduce Incidence.术前全身免疫炎症指数作为乳腺癌手术后下肢深静脉血栓形成的预测生物标志物:分层护理干预以降低发生率。
Med Sci Monit. 2023 Dec 17;29:e942087. doi: 10.12659/MSM.942087.

引用本文的文献

1
Two sides of the coin: coagulation and inflammation in deep vein thrombosis - a prospective study on D-dimer and SIRI.硬币的两面:深静脉血栓形成中的凝血与炎症——一项关于D-二聚体和全身炎症反应指数的前瞻性研究
Front Med (Lausanne). 2025 Aug 11;12:1604286. doi: 10.3389/fmed.2025.1604286. eCollection 2025.
2
A prospective cohort study on the joint associations of abdominal aortic calcification and systemic inflammation response index with mortality risk.一项关于腹主动脉钙化与全身炎症反应指数联合作用对死亡风险影响的前瞻性队列研究。
Sci Rep. 2025 Apr 18;15(1):13421. doi: 10.1038/s41598-025-98485-z.
3
Association between stroke and systemic inflammation response index (SIRI): a National Health and Nutrition Examination Survey (NHANES) Study 2015-2020.

本文引用的文献

1
Association between systemic immune-inflammation index and risk of lower extremity deep venous thrombosis in hospitalized patients: a 10-year retrospective analysis.住院患者全身免疫炎症指数与下肢深静脉血栓形成风险的相关性:一项10年回顾性分析
Front Cardiovasc Med. 2023 Jun 16;10:1211294. doi: 10.3389/fcvm.2023.1211294. eCollection 2023.
2
Platelet‑to‑lymphocyte ratio, neutrophil‑to‑lymphocyte ratio and monocyte‑to‑HDL cholesterol ratio as helpful biomarkers for patients hospitalized for deep vein thrombosis.血小板与淋巴细胞比值、中性粒细胞与淋巴细胞比值和单核细胞与高密度脂蛋白胆固醇比值可作为深静脉血栓形成住院患者的有用生物标志物。
Int J Mol Med. 2023 Jun;51(6). doi: 10.3892/ijmm.2023.5255. Epub 2023 May 11.
3
中风与全身炎症反应指数(SIRI)之间的关联:一项2015 - 2020年美国国家健康与营养检查调查(NHANES)研究
BMJ Neurol Open. 2025 Mar 3;7(1):e000718. doi: 10.1136/bmjno-2024-000718. eCollection 2025.
4
Association between neutrophile-to-lymphocyte ratio and risk of deep vein thrombosis in patient receiving lower extremity orthopedic surgery: A meta-analysis.接受下肢骨科手术患者中性粒细胞与淋巴细胞比值与深静脉血栓形成风险的关联:一项荟萃分析。
PLoS One. 2025 Feb 24;20(2):e0319107. doi: 10.1371/journal.pone.0319107. eCollection 2025.
5
Prognostic Nutritional Index as a Potential Biomarker for the Risk of Lower Extremity Deep Venous Thrombosis: A Large Retrospective Study.预后营养指数作为下肢深静脉血栓形成风险的潜在生物标志物:一项大型回顾性研究
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251317520. doi: 10.1177/10760296251317520.
6
The systemic inflammation response index as a significant predictor of short-term adverse outcomes in acute decompensated heart failure patients: a cohort study from Southern China.全身炎症反应指数作为急性失代偿性心力衰竭患者短期不良结局的重要预测指标:一项来自中国南方的队列研究。
Front Endocrinol (Lausanne). 2024 Dec 23;15:1444663. doi: 10.3389/fendo.2024.1444663. eCollection 2024.
7
Association of systemic inflammation response index with mortality risk in older patients with hip fracture: a 10-year retrospective cohort study.全身炎症反应指数与老年髋部骨折患者死亡风险的关联:一项10年回顾性队列研究
Front Med (Lausanne). 2024 May 22;11:1401443. doi: 10.3389/fmed.2024.1401443. eCollection 2024.
8
Evidence for causal effects of neuropsychiatric conditions on risk of venous thromboembolism: A univariable and multivariable Mendelian randomization study.神经精神疾病对静脉血栓栓塞风险影响的因果关系证据:单变量和多变量孟德尔随机化研究。
J Vasc Surg Venous Lymphat Disord. 2024 Nov;12(6):101889. doi: 10.1016/j.jvsv.2024.101889. Epub 2024 Apr 15.
9
Should we consider Systemic Inflammatory Response Index (SIRI) as a new diagnostic marker for rectal cancer?我们是否应将全身炎症反应指数(SIRI)视为直肠癌的一种新的诊断标志物?
Discov Oncol. 2024 Feb 21;15(1):44. doi: 10.1007/s12672-024-00895-4.
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis.
口服直接凝血酶抑制剂或口服因子 Xa 抑制剂与传统抗凝剂治疗深静脉血栓形成的比较。
Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD010956. doi: 10.1002/14651858.CD010956.pub3.
4
Inflammation index SIRI is associated with increased all-cause and cardiovascular mortality among patients with hypertension.炎症指标SIRI与高血压患者全因死亡率和心血管死亡率增加有关。
Front Cardiovasc Med. 2023 Jan 11;9:1066219. doi: 10.3389/fcvm.2022.1066219. eCollection 2022.
5
Association of inflammation indices with left atrial thrombus in patients with valvular atrial fibrillation.炎症指标与瓣膜性心房颤动患者左心房血栓的相关性。
BMC Cardiovasc Disord. 2023 Jan 9;23(1):9. doi: 10.1186/s12872-023-03036-x.
6
Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial.利伐沙班治疗有症状的孤立性远端深静脉血栓形成患者 6 周与 3 个月:随机对照试验。
BMJ. 2022 Nov 23;379:e072623. doi: 10.1136/bmj-2022-072623.
7
Prognostic Nutritional Index, Controlling Nutritional Status (CONUT) Score, and Inflammatory Biomarkers as Predictors of Deep Vein Thrombosis, Acute Pulmonary Embolism, and Mortality in COVID-19 Patients.预后营养指数、控制营养状况(CONUT)评分及炎症生物标志物作为COVID-19患者深静脉血栓形成、急性肺栓塞和死亡率的预测指标
Diagnostics (Basel). 2022 Nov 11;12(11):2757. doi: 10.3390/diagnostics12112757.
8
Trends and Risk Factors for Venous Thromboembolism Among Hospitalized Medical Patients.住院内科患者静脉血栓栓塞症的趋势和风险因素。
JAMA Netw Open. 2022 Nov 1;5(11):e2240373. doi: 10.1001/jamanetworkopen.2022.40373.
9
Inflammatory Biomarkers as Prognostic Factors of Acute Deep Vein Thrombosis Following the Total Knee Arthroplasty.炎症生物标志物作为全膝关节置换术后急性深静脉血栓形成的预后因素。
Medicina (Kaunas). 2022 Oct 21;58(10):1502. doi: 10.3390/medicina58101502.
10
Dynamic Status of SII and SIRI Alters the Risk of Cardiovascular Diseases: Evidence from Kailuan Cohort Study.全身免疫炎症指数(SII)和全身炎症反应指数(SIRI)的动态变化影响心血管疾病风险:来自开滦队列研究的证据
J Inflamm Res. 2022 Oct 21;15:5945-5957. doi: 10.2147/JIR.S378309. eCollection 2022.